Cancer Letters

Article	Citations
Extrinsic factors associated with the response to immunotherapy in glioblastoma	328
Editorial Board	300
Ethnic Diversity and Metabolic Variations in Ovarian Cancer Cells: Implications for Personalized Medicine Strategies	253
Versatility of Exosomes for Cancer Therapy	249
Editorial Board	193
ASPH dysregulates cell death and induces chemoresistance in hepatocellular carcinoma	156
An emerging aspect of cancer neuroscience: A literature review on chemotherapy-induced peripheral neuropathy	148
Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor model	148
Nervous system in colorectal cancer	143
IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myeloma	134
Bypassing the Tollway; a novel path to TLR4 independent stemness regulation	123
LCAT deficiency promotes hepatocellular carcinoma progression and lenvatinib resistance by promoting triglyceride catabolism and fatty acid oxidation	123
Intratumoral injection of mRNA encoding survivin in combination with STAT3 inhibitor stattic enhances antitumor effects	121
CXCL13 promotes intestinal tumorigenesis through the activation of epithelial AKT signaling	117
Coiled-coil domain-containing 154 promotes colorectal cancer proliferation and metastasis via interacting with minichromosome maintenance complex component 2	116
Hypoxia effects on glioblastoma progression through YAP/TAZ pathway regulation	112
KAT7 enhances the proliferation and metastasis of head and neck squamous carcinoma by promoting the acetylation level of LDHA	109
Regulation of gut microbiota on immune cell ferroptosis: A novel insight for immunotherapy against tumor	107
ERBB3 targeting: A promising approach to overcoming cancer therapeutic resistance	99
Sphingosine-1 phosphate receptor 1 (S1PR1) expression maintains stemness of acute myeloid leukemia stem cells	96
Induction of EnR stress by Melatonin enhances the cytotoxic effect of Lapatinib in HER2-positive breast cancer	95
PROTACs: Novel tools for improving immunotherapy in cancer	94
Osteopontin promotes tumor microenvironment remodeling and therapy resistance	92
Editorial Board	92
Evaluation and preservation of fertility in patients with hematologic malignancies	90

Targeted inhibition of the expression of both MCM5 and MCM7 by miRNA-214 impedes DNA replication and tumorigenesis in hepatocellular carcinoma cells	89
Targeted inhibition of acidic nucleoplasmic DNA-binding protein 1 enhances radiosensitivity of non-small cell lung cancer	87
Intracellular AGR2 transduces PGE2 stimuli to promote epithelial–mesenchymal transition and metastasis of colorectal cancer	87
CD155 in tumor progression and targeted therapy	86
Combination treatment with 17β-estradiol and anti-PD-L1 suppresses MC38 tumor growth by reducing PD-L1 expression and enhancing M1 macrophage population in MC38 colon tumor model	85
The E3 ligase TRIM22 functions as a tumor suppressor in breast cancer by targeting CCS for proteasomal degradation to inhibit STAT3 signaling	85
Dual mTORC1/2 inhibitor AZD2014 diminishes myeloid-derived suppressor cells accumulation in ovarian cancer and delays tumor growth	84
MDSCs in bone metastasis: Mechanisms and therapeutic potential	83
Targeting p53 for immune modulation: Exploring its functions in tumor immunity and inflammation	82
Cancer-associated fibroblasts in non-small cell lung cancer: Recent advances and future perspectives	80
Metronomic chemotherapy regimens and targeted therapies in non-Hodgkin lymphoma: The best of two worlds	79
Interleukin-17 activates and synergizes with the notch signaling pathway in the progression of pancreatic ductal adenocarcinoma	78
The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes	77
CD147-specific chimeric antigen receptor T cells effectively inhibit T cell acute lymphoblastic leukemia	76
Accelerating the clinical translation of CD70-targeted chimeric antigen receptor-based cell therapies in oncology: A comprehensive clinical investigation panorama analysis based on the Trialtrove data	75
PI3K inhibitor impairs tumor progression and enhances sensitivity to anlotinib in anlotinib-resistant osteosarcoma	73
METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth	73
Tuning cellular metabolism for cancer virotherapy	72
Increasing membrane polyunsaturated fatty acids sensitizes non-small cell lung cancer to anti-PD-1/PD-L1 immunotherapy	72
CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy	72
Clinical development of immuno-oncology therapeutics	71
Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagy	70
Neoantigen discovery and applications in glioblastoma: An immunotherapy perspective	69
Fatty acids in cancer chemoresistance	67
Ubiquitin-specific peptidase 22 in cancer	66
FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity	64
Jolkinolide B targets thioredoxin and glutathione systems to induce ROS-mediated paraptosis and apoptosis in bladder cancer cells	64
The role of Hippo/YAP1 in cancer-associated fibroblasts: Literature review and future perspectives	63
TIM3 on natural killer cells regulates antibody-dependent cellular cytotoxicity in HER2-positive gastric cancer	63
Understanding the significance of biological clock and its impact on cancer incidence	63
The interplay between autophagy and apoptosis: its implication in lung cancer and therapeutics	63
Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion, migration, proliferation and stemness of pancreatic cancer cells by sponging miR-338-5p and targeting the Wif1/Wnt8/β-catenin axis	63
M6A-modified lncRNA FAM83H-AS1 promotes colorectal cancer progression through PTBP1	62
Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors?	62
A natural compound melatonin enhances the effects of Nimotuzumab via inhibiting EGFR in glioblastoma	62
Tumor-targeted exosomes for delivery of anticancer drugs	62
Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer	60
ANKZF1 knockdown inhibits glioblastoma progression by promoting intramitochondrial protein aggregation through mitoRQC	58
S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE/NF-kB/VEGF-D pathway	57
XRCC2 repairs mitochondrial DNA damage and fuels malignant behavior in hepatocellular carcinoma	57
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair	56
Targeting the genetic landscape of oral potentially malignant disorders has the potential as a preventative strategy in oral cancer	56
Understanding the cellular origin and progression of esophageal cancer using esophageal organoids	56
Cytomegalovirus infection of glioblastoma cells leads to NF-κB dependent upregulation of the c-MET oncogenic tyrosine kinase	55
ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3	55
Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia	55
Store-operated Ca2+ entry as a key oncogenic Ca2+ signaling driving tumor invasion-metastasis cascade and its translational potential	54
Calcium channel TRPV6 promotes breast cancer metastasis by NFATC2IP	54
The Tn antigen promotes lung tumor growth by fostering immunosuppression and angiogenesis via interaction with Macrophage Galactose-type lectin 2 (MGL2)	54
Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2→CNTF axis to promote progression of brain metastases	53

An effective two-stage NMBzA-induced rat esophageal tumor model revealing that the FAT-Hippo-YAP1 axis drives the progression of ESCC	52
Glucose restriction induces ROS-AMPK-mediated CTR1 expression and increases cisplatin efficiency in NSCLC	52
Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity	52
FOXF2 expression triggered by endocrine therapy orchestrates therapeutic resistance through reorganization of chromatin architecture in breast cancer	51
Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenocarcinoma	51
Inhibition of T-antigen expression promoting glycogen synthase kinase 3 impairs merkel cell carcinoma cell growth	50
Targeting Amino Acid Dependency for Cancer Treatment	50
Letter to the editor on ‘A deep neural network predictor to predict the sensitivity of neoadjuvant chemoradiotherapy in locally advanced rectal cancer’	50
Corrigendum to “Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGFβ signaling pathway” [Canc. Lett. (2023) 2161	50
Improved antitumor effects elicited by an oncolytic HSV-1 expressing a novel B7H3nb/CD3 BsAb	50
Editorial Board	50
Corrigendum to “UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation” [Canc. Lett. 494 (20	50
A feedback circuit comprising EHD1 and 14-3-3ζ sustains β-catenin/c-Myc-mediated aerobic glycolysis and proliferation in non-small cell lung cancer	49
Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer	49
Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a/Nfatc1/Angptl2 axis for bone metastasis	49
R-spondin-3 promotes proliferation and invasion of breast cancer cells independently of Wnt signaling	49
MEK-mediated CHPF2 phosphorylation promotes colorectal cancer cell proliferation and metastasis by activating NF-κB signaling	48
Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives	48
The combination of gemcitabine plus an anti-FGFR inhibitor can have a synergistic antitumor effect on FGF-activating cholangiocarcinoma	48
Isorhapontigenin (ISO) inhibits EMT through FOXO3A/METTL14/VIMENTIN pathway in bladder cancer cells	48
MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway	46
LKB1 inhibits telomerase activity resulting in cellular senescence through histone lactylation in lung adenocarcinoma	46
Plasmacytoid dendritic cells recruited by HIF-1α/eADO/ADORA1 signaling induce immunosuppression in hepatocellular carcinoma	46
Sonrotoclax (BGB-11417) synergistically amplifies the radiotherapy-elicited anti-tumor immune response	46
The intratumoral microbiome: Characterization methods and functional impact	46
Emerging roles of lysosome homeostasis (repair, lysophagy and biogenesis) in cancer progression and therapy	46
Single-cell chemokine receptor profiles delineate the immune contexture of tertiary lymphoid structures in head and neck squamous cell carcinoma	45
PPAR agonists attenuate lenalidomide's anti-myeloma activity in vitro and in vivo	45
The feedback loop of AURKA/DDX5/TMEM147-AS1/let-7 drives lipophagy to induce cisplatin resistance in epithelial ovarian cancer	44
Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses	44
Single-cell RNA-sequencing of human spleens reveals an IDO-1+ tolerogenic dendritic cell subset in pancreatic cancer patients that is absent in normal individuals	44
Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula	44
DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer	43
Nanomaterials in crossroad of autophagy control in human cancers: Amplification of cell death mechanisms	42
Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy	42
Low-dose metronomic chemotherapy triggers oxidized mtDNA sensing inside tumor cells to potentiate CD8+T anti-tumor immunity	42
Application prospect of circular RNA-based neoantigen vaccine in tumor immunotherapy	42
Tumor-nerve interactions in cancer regulation and progression	41
Copper in hepatocellular carcinoma： A double-edged sword with therapeutic potentials	41
Radiotherapy-induced tumor physical microenvironment remodeling to overcome immunotherapy resistance	41
A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study	41
Fas signaling in adipocytes promotes low-grade inflammation and lung metastasis of colorectal cancer through interaction with Bmx	41
CircUBE3A(2,3,4,5) promotes adenylate-uridylate-rich binding factor 1 nuclear translocation to suppress prostate cancer metastasis	41
Exercise in cancer prevention and anticancer therapy: Efficacy, molecular mechanisms and clinical information	41
RNA binding protein RALY activates the cholesterol synthesis pathway through an MTA1 splicing switch in hepatocellular carcinoma	41
ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response in pancreatic cancer	41
Corrigendum to “Circular RNA ciRS-7 accelerates ESCC progression through acting as a miR-876-5p sponge to enhance MAGE-A family expression” [Cancer Lett. 426 (2018) 37–46]	40
Sorbitol dehydrogenase induction of cancer cell necroptosis and macrophage polarization in the HCC microenvironment suppresses tumor progression	40
Pan-cancer atlas of tumor-resident microbiome, immunity and prognosis	40
Corrigendum to “P-REX1 amplification promotes progression of cutaneous melanomavia the PAK1/P38/MMP-2 pathway” [Cancer Lett. 407 (2017) 66–75]	40
The post-chemotherapy changes of tumor physical microenvironment: Targeting extracellular matrix to address chemoresistance	40
Interplay among extracellular vesicles, cancer stemness and immune regulation in driving hepatocellular carcinoma progression	40
LINC00978 regulates metabolic rewiring to promote the malignancy of glioblastoma through AKR1B1	40
Circular RNA circPFKP promotes cell proliferation by activating IMPDH2 in prostate cancer	40
GPRC5A promotes gallbladder cancer metastasis by upregulating TNS4 via the JAK2–STAT3 pathway	39
Treatment strategies and molecular mechanism of radiotherapy combined with immunotherapy in colorectal cancer	39
Long noncoding RNA lnc-LEMGC combines with DNA-PKcs to suppress gastric cancer metastasis	39
Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of Dicer to accelerate triple-negative breast cancer progression	39
Retraction notice to “MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5” [Canc. Lett. 322 (2012) 148–158]	39
Functional genomic approaches in acute myeloid leukemia: Insights into disease models and the therapeutic potential of reprogramming	39
Editorial Board	39
Remodeling of tumor microenvironment by extracellular matrix protein 1a differentially regulates ovarian cancer metastasis	39
Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer	39
Activating Sphingosine-1-phospahte signaling in endothelial cells increases myosin light chain phosphorylation to decrease endothelial permeability thereby inhibiting cancer metastasis	39
Active immunization with a structurally aggregated PD-L1 antigen breaks T and B immune tolerance in non-human primates and exhibits in vivo anti-tumoral effects in immunocompetent mouse tumor models	39
Decoding the potential microbiome modulation strategies from bugs to drugs in pancreatic cancer: Insights from clinical trials	38
WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity	38
Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies	38
Gold nanoparticles and obese adipose tissue microenvironment in cancer treatment	38
hnRNPLL regulates MYOF alternative splicing and correlates with early metastasis in pancreatic ductal adenocarcinoma	37
WEE1 confers resistance to KRASG12C inhibitors in non-small cell lung cancer	37
Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges	37
REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activity	37
Smoking-induced CCNA2 expression promotes lung adenocarcinoma tumorigenesis by boosting AT2/AT2-like cell differentiation	37
Develop a Novel Therapy for Pancreatic Cancer	37
Editorial Board	36
Phosphorylation of PBK/TOPK Tyr74 by JAK2 promotes Burkitt lymphoma tumor growth	36
Phase separation of EEF1E1 promotes tumor stemness via PTEN/AKT-mediated DNA repair in hepatocellular carcinoma	36
Editorial Board	36
Non-muscle myosin II isoforms orchestrate substrate stiffness sensing to promote cancer cell contractility and migration	36

Editorial Board	36
Human mesenchymal stromal cells maintain their stem cell traits after high-LET particle irradiation – Potential implications for particle radiotherapy and manned space missions	36
The safety and efficacy outcomes of Minnelide given alone or in combination with paclitaxel in advanced gastric cancer: A phase I trial	36
Letter to the editor regarding “Dual blockade of EGFR and CDK4/6 delays head and neck squamous cell carcinoma progression by inducing metabolic rewiring."	35
Corrigendum to “Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and paracrine signaling in metastatic pancreatic cancer” [Cancer Lett. 456 (2019 Aug 1) 1	35
Dysregulation of autophagy in gastric carcinoma: Pathways to tumor progression and resistance to therapy	35
Mitochondrial fragmentation in liver cancer: Emerging player and promising therapeutic opportunities	35
Identification of SMARCAL1 as a molecular target for small cell lung cancer treatment	35
Long noncoding RNA KB-1460A1.5 inhibits glioma tumorigenesis via miR-130a-3p/TSC1/mTOR/YY1 feedback loop	35
TRF2 cooperates with CTCF for controlling the oncomiR-193b-3p in colorectal cancer	35
Editorial Board	35
Corrigendum to “Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer” [Canc. Lett. 374 (2016) 292–303]	35
Depression in breast cancer patients: Immunopathogenesis and immunotherapy	35
High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcoma	34
Super-giant cells: Toward understanding tumor origins on the organismal level	34
WITHDRAWN: Proteomic analysis of plasma-derived exosomes identifies biomarkers that distinguish brain and liver metastasis in lung cancer patients	34
A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression	34
A journey to excellence: Disseminating groundbreaking discoveries in oncology research	34
Editorial Board	34
Circadian disruption in cancer and regulation of cancer stem cells by circadian clock genes: An updated review	34
Corrigendum to “NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization” [Cancer Lett. (2024) 597 217059]	34
Editorial Board	34
The eIF3a translational control axis in the Wnt/β-catenin signaling pathway and colon tumorigenesis	34
Revisiting the advances and challenges in the clinical applications of extracellular vesicles in cancer	33
Dual targeting PPARα and NPC1L1 metabolic vulnerabilities blocks tumorigenesis	33
Biodistribution and therapeutic efficacy of a gold nanoparticle-based targeted drug delivery system against pancreatic cancer	33
Single-nucleus sequencing unveils heterogeneity in renal cell carcinomas microenvironment: Insights into pathogenic origins and treatment-responsive cellular subgroups	33
EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of Snail	33
Single-cell transcriptomics reveals intratumor heterogeneity and the potential roles of cancer stem cells and myCAFs in colorectal cancer liver metastasis and recurrence	33
E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis	33
PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer	33
Deciphering the tumor-suppressive role of PSMB9 in melanoma through multi-omics and single-cell transcriptome analyses	33
Histone lactylation dynamics: Unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer	33
Disparities in mortality risk after diagnosis of hematological malignancies in 185 countries: A global data analysis	33
RNA methyltransferase METTL16: from molecular mechanisms to therapeutic prospects in cancers	33
LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack	32
SLC7A11/ xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells	32
CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma	32
Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming	32
Targeting the molecular chaperone CCT2 inhibits GBM progression by influencing KRAS stability	32
Identification of SPP1+ macrophages in promoting cancer stemness via vitronectin and CCL15 signals crosstalk in liver cancer	32
Emerging insights into origin and pathobiology of primary central nervous system lymphoma	32
Cancer-associated fibroblasts activated by miR-196a promote the migration and invasion of lung cancer cells	32
Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer	32
Targeted inhibition of CHKα and mTOR in models of pancreatic ductal adenocarcinoma: A novel regimen for metastasis	32
Lipid metabolism reprogramming of CD8+ T cell and therapeutic implications in cancer	32
The mitotic regulator RCC2 promotes glucose metabolism through BACH1-dependent transcriptional upregulation of hexokinase II in glioma	32
FGL2-wired macrophages secrete CXCL7 to regulate the stem-like functionality of glioma cells	32
CPSF3 regulates alternative polyadenylation of CNIH2 to promote esophageal squamous cell carcinoma progression	32
Aging of the progenitor cells that initiate prostate cancer	32
Editorial Board	31
Inflammatory cytokine-regulated LNCPTCTS suppresses thyroid cancer progression via enhancing Snail nuclear export	31
TFAP2C-DDR1 axis regulates resistance to CDK4/6 inhibitor in breast cancer	31
Editorial Board	31
Editorial Board	31
Editorial Board	31
IgSF protein EWI2 is a tumor suppressor	31
Editorial Board	31
Editorial Board	31
Significance of longitudinal Epstein–Barr virus DNA combined with multipoint tumor response for dynamic risk stratification and treatment adaptation in nasopharyngeal carcinoma	31
Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma	30
Extracellular vesicle biomarkers redefine prostate cancer radiotherapy	30
A novel microenvironment regulated system CAR-T (MRS.CAR-T) for immunotherapeutic treatment of esophageal squamous carcinoma	30
ITPR1-AS1 promotes small cell lung cancer metastasis by facilitating P21 splicing and stabilizing DDX3X to activate the cRaf-MEK-ERK cascade	30
Multi-functional extracellular vesicles: Potentials in cancer immunotherapy	30
The nuclear condensates of ESE3/EHF induce cellular senescence without the associated inflammatory secretory phenotype in pancreatic ductal adenocarcinoma	30
Confusion about the article: Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ	30
Harnessing genetic interactions for prediction of immune checkpoint inhibitors response signature in cancer cells	30
Cancer-associated fibroblasts: A key target to snatch victory from defeat in therapy resistance associated with the pancreatic cancer stroma	30
Proteolysis of a histone acetyl reader, ATAD2, induces chemoresistance of cancer cells under severe hypoxia by inhibiting cell cycle progression in S phase	30
PPDPF promotes esophageal squamous cell carcinoma progression by blocking PCCA binding to PCCB and inhibiting methionine catabolism	30
Loss of ASAP1 in the MMTV-PyMT model of luminal breast cancer activates AKT, accelerates tumorigenesis, and promotes metastasis	29
Tumor-derived extracellular vesicles induce invalid cytokine release and exhaustion of CD19 CAR-T Cells	29
The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance	29
Metformin inhibits neutrophil extracellular traps-promoted pancreatic carcinogenesis in obese mice	29
Cancer-associated fibroblast-like fibroblasts in vocal fold leukoplakia suppress CD8+T cell functions by inducing IL-6 autocrine loop and interacting with Th17 cells	29
Mutant IDH1 promotes phagocytic function of microglia/macrophages in gliomas by downregulating ICAM1	29
circCCNY enhances lenvatinib sensitivity and suppresses immune evasion in hepatocellular carcinoma by serving as a scaffold for SMURF1 mediated HSP60 degradation	29
Inhibition of the endosomal recycling pathway downregulates HER2 activation and overcomes resistance to tyrosine kinase inhibitors in HER2-positive breast cancer	29
CHEK2 deficiency increase the response to PD-1 inhibitors by affecting the tumor immune microenvironment	29
AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells	29
Evolution and contemporary role of metronomic chemotherapy in the treatment of neuroblastoma	29
The novel long noncoding RNA AU021063, induced by IL-6/Arid5a signaling, exacerbates breast cancer invasion and metastasis by stabilizing Trib3 and activating the Mek/Erk pathway	29
HMGB1 in the interplay between autophagy and apoptosis in cancer	29
Deciphering the immune modulation through deep transcriptomic profiling and therapeutic implications of DNA damage repair pattern in hepatocellular carcinoma	29
A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resistance	29
EMMPRIN in extracellular vesicles from peritoneal mesothelial cells stimulates the invasion activity of diffuse-type gastric cancer cells	28
Corrigendum to “Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer [Cancer Lett. 379 (2016) 1–11]	28
Energy stress-activated AMPK phosphorylates Snail1 and suppresses its stability and oncogenic function	28
The mammalian Sterile 20-like kinase 4 (MST4) signaling in tumor progression: Implications for therapy	28
SMEK1 promotes clear cell renal cell carcinoma progression via EGFR tyrosine-kinase dependent pathway	28
m6A demethylation of NNMT in CAFs promotes gastric cancer progression by enhancing macrophage M2 polarization	28
HSP90 inhibitor AUY922 suppresses tumor growth and modulates immune response through YAP1-TEAD pathway inhibition in gastric cancer	28
Unraveling the NLRP family: Structure, function, activation, critical influence on tumor progression, and potential as targets for cancer therapy	28
Circulating tumor cell abundance in head and neck squamous cell carcinoma decreases with successful chemoradiation and cetuximab treatment	28